Nontuberculous Mycobacteria treatment

View All

NTM infection drug pipeline
Bridging the gap: Nontuberculous mycobacterium Infections Drug Pipeline

Slowly or rapidly growing bacteria- Nontuberculous mycobacteria (NTM), might appear innocuous, however, NTM infections have a notably higher total prevalence of 3,65,273 in the 7MM, estimates DelveInsight. Despite the global prevalence, clear from the facts and figures, the available therapies are entirely on an in...

Find More

Nontuberculous Mycobacteria Infection
Lack of effective therapy: A major Nontuberculous Mycobacteria Infection Market Driver

Nontuberculous Mycobacteria (NTM) is a ubiquitous, aerobic, non-motile, acid-fast bacteria, which, when inhaled, may cause severe lung disorders. Especially common in the elderly, individuals with lung diseases, slender caucasian women, and people with esophageal disorders, NTM affects both healthy persons and thos...

Find More